Increasing use of allogeneic hematopoietic cell transplantation in patients aged 70 years and older in the United StatesLori Muffly, William A. Wood, Jean‐Yves Cahn et al.|Blood|2017Cited by 296
Outcomes of haploidentical vs matched sibling transplantation for acute myeloid leukemia in first complete remissionArmin Rashidi, Richard F. Olsson, Mehdi Hamadani et al.|Blood Advances|2019Cited by 128
Second Solid Cancers after Allogeneic Hematopoietic Cell Transplantation Using Reduced-Intensity ConditioningOlle Ringdén, Navneet S. Majhail, Ruta Brazauskas et al.|Biology of Blood and Marrow Transplantation|2014Cited by 67
Long-Term Survival and Late Effects among One-Year Survivors of Second Allogeneic Hematopoietic Cell Transplantation for Relapsed Acute Leukemia and Myelodysplastic SyndromesChristine Duncan, Mohamed L. Sorror, Navneet S. Majhail et al.|Biology of Blood and Marrow Transplantation|2014Cited by 64
Comparative Analysis of Calcineurin Inhibitor–Based Methotrexate and Mycophenolate Mofetil–Containing Regimens for Prevention of Graft-versus-Host Disease after Reduced-Intensity Conditioning Allogeneic TransplantationSaurabh Chhabra, Betty K. Hamilton, Ying Liu et al.|Biology of Blood and Marrow Transplantation|2018Cited by 51